DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Steven S, Oelze M, Hanf A. et al
The SGLT-2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats.
Redox Biology 2017;
13: 370-385 . doi:10.1016/j.redox.2017.06.009
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.